Project Details
Description
DESCRIPTION: This proposal examines the ability of vitamin-D and its
derivatives to regulate cell growth in colonic cancer. The applicant and
his coworkers have shown that F6-D3, a fluorinated, non-calcemic analog of
1-alpha,25 (OH)2-D3 reduced the incidence of colonic adenomas and prevented
the development of adenocarcinomas in experimental models. In order to
understand the role of vitamin D3 in colonic normal and abnormal function,
studies are proposed in normal rat colon and in CaCo-2 cells, a cell line
derived from a human colonic adenocarcinoma. The cells exhibit similar
signal transduction mechanisms and respond in similar fashion to vitamin D
as their normal counterparts. Previous studies have shown that vitamin D
and F6-D3 decreased cellular proliferation in these cells, while more recent
studies have shown that they induce growth arrest in the G1 phase of cell
cycle and bring about apoptosis. Accordingly the specific aims of the
proposal are to characterize the mechanisms involved in inhibition of
cellular proliferation in CaCo-2 cells and the actions of the secosteroids
in inducing apoptosis.
| Status | Finished |
|---|---|
| Effective start/end date | 11/9/02 → 03/31/04 |
Funding
- National Inst of Diabetes Digestive Kidney Disease: $60,263.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.